>
세포 및 유전자 치료제 개발 및 평가 솔루션
GMP 등급 사이토카인
형광성 스팟 라벨링 제품
관련 타깃 단백질
항이디오타입 항체
마그네틱 비드
뉴클레아제
사이토카인 검출 키트
분자 | 제품 번호 | 제품 설명 | 주문/예약 |
---|---|---|---|
IL-15 | GMP-L15H13 | GMP Human IL-15 | |
IL-7 | GMP-L07H24 | GMP Human IL-7 | |
IL-21 | GMP-L21H25 | GMP Human IL-21 |
Fluorescent Labels | Molecule | Cat. No. | Product Description | Preorder/Order |
---|
Molecule | Cat. No. | Antigen | Neutralizing Activity | Application |
---|---|---|---|---|
Adalimu*ab | ADB-Y19 | Anti-Adalimu*ab Antibodies (AY19) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Adalimu*ab | ADB-Y23b | Anti-Adalimu*ab Antibodies (AY23b) (recommended for PK/PD) | Non-Neutralizing Antibody | PK bridging ELISA; Indirect ELISA |
Bevacizu*ab | BEB-Y10 | Anti-Bevacizu*ab Antibodies (AY10) (MALS verified, recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA; Neutralizing assay; Indirect ELISA |
Bevacizu*ab | BEB-Y12 | Anti-Bevacizu*ab Antibodies (AY12) (recommended for neutralizing assay) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Bevacizu*ab | BEB-Y9 | Anti-Bevacizu*ab Antibodies (AY9) (recommended for ADA assay) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Bevacizu*ab | BEB-BY13 | Biotinylated Anti-Bevacizu*ab Antibodies (AY13) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA;Neutralizing assay; Indirect ELISA |
Cetuxi*ab | CEB-Y27 | Anti-Cetuxi*ab Antibodies (AY27) (recommended for ADA assay) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Cetuxi*ab | CEB-Y31 | Anti-Cetuxi*ab Antibodies (AY31) (Non-Neutralizing) | Non-Neutralizing Antibody | ADA assay; Indirect ELISA |
Cetuxi*ab | CEB-Y29 | Anti-Cetuxi*ab Antibodies (AY29) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA; Neutralizing assay; Indirect ELISA |
Cetuxi*ab | CEB-Y28 | Anti-Cetuxi*ab Antibodies (AY28) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Cetuxi*ab | CEB-BY31 | Biotinylated Anti-Cetuxi*ab Antibodies (AY31) (recommended for PK/PD) | Non-Neutralizing Antibody | PK bridging ELISA; Indirect ELISA |
Rituxi*ab | RIB-Y36 | Anti-Rituxi*ab Antibodies (AY36) (recommended for ADA assay) | Neutralizing Antibody | ADA assay;Neutralizing assay; Indirect ELISA |
Rituxi*ab | RIB-Y37 | Anti-Rituxi*ab Antibodies (AY37) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA;Neutralizing assay;Indirect ELISA |
Rituxi*ab | RIB-FY35c | FITC-Labeled Anti-Rituxi*ab Antibodies, Mouse IgG1 | Neutralizing Antibody | ADA assay;Neutralizing assay; Indirect ELISA |
Rituxi*ab | RIB-Y35c | Anti-Rituxi*ab Antibodies (MALS verified) | Non-Neutralizing Antibody | ADA assay; Indirect ELISA |
Trastuzu*ab | TRB-Y5b | Anti-Trastuzu*ab Antibodies (AY5b) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA |
Trastuzu*ab | TRB-Y1b | Anti-Trastuzu*ab Antibodies (AY1b) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA; Neutralizing assay; Indirect ELISA |
제품 번호 | 제품 설명 | 권장 응용 | 주문/선주문 |
---|---|---|---|
MBS-C001 | Human T cell Activation/Expansion CD3/CD28 Beads, premium grade DMF Filed | Cell activation and expansion |
분자 | 제품 번호 | 제품 설명 | 주문/선주문 |
---|---|---|---|
Cas9 | CA9-S5149 | NLS-Cas9 Nuclease | |
Cas12a | CAA-L5149 | NLS-Cas12a Nuclease | |
BenzNuclease | GMP-NUES19 | GENIUS™Nuclease DMF Filed |
Molecule | Cat. No. | Product Description |
---|---|---|
IFN-γ | CRS-A017 | Human Interferon-γ(IFN-γ) ELISA Kit |
TNF-α | CRS-A002 | Human Tumor Necrosis Factor Alpha(TNF-α) ELISA Kit |
IL-2 | CRS-A003 | Human Interleukin-2(IL-2) ELISA Kit |
GM-CSF | CRS-A013 | Human Macrophage Colony Stimulating Factor 2(GM-CSF) ELISA Kit |
IL-7 | CRS-A006 | Human Interleukin-7(IL-7) ELISA Kit |
IL-15 | CRS-A009 | Human Interleukin-15(IL-15) ELISA Kit |
IL-21 | CRS-A010 | Human Interleukin-21(IL-21) ELISA Kit |
This web search service is supported by Google Inc.